|
Luengo-Gil G, González-Billalabeitia E, Chaves-Benito A, García Martínez E, García Garre E, Vicente V, Ayala de la Peña F. Effects of conventional neoadjuvant chemotherapy for breast cancer on tumor angiogenesis. Breast Cancer Res Treat. 2015 Jun;151(3):577-87. doi: 10.1007/s10549-015-3421-4. PubMed PMID: 25967462.
AÑO: 2015; IF: 4.085
|
25967462
|
García-Martínez E, Gil GL, Benito AC, González-Billalabeitia E, Conesa MA, García García T, García-Garre E, Vicente V, Ayala de la Peña F. Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer. Breast Cancer Res. 2014 Nov 29;16(6):488. doi: 10.1186/s13058-014-0488-5. PubMed PMID: 25432519; PubMed Central PMCID: PMC4303200.
AÑO: 2014; IF: 5.49
|
|
Llorente A, Perez-Valero I, García E, Heras I, Fraile V, García P, López J, Salavert M, Bobillo F. Mortality risk factors in patients with zygomycosis: a retrospective and multicentre study of 25 cases. Enferm Infecc Microbiol Clin. 2011 Apr;29(4):263-8. doi: 10.1016/j.eimc.2010.09.008. Epub 2011 Feb 16. PubMed PMID: 21330008.
AÑO: 2011; IF: 1.491
|
|
Pérez-Fidalgo JA, Roselló S, García-Garré E, Jordá E, Martín-Martorell P, Bermejo B, Chirivella I, Guzman C, Lluch A. Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens. Breast Cancer Res Treat. 2010 Feb;120(1):245-51. doi: 10.1007/s10549-009-0426-x. Epub 2009 Jul 3. PubMed PMID: 19575291.
AÑO: 2010; IF: 4.859
|